| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/23/2013 | CN103356694A Pharmaceutical agent having long-lasting effect of treating arthritic disorders |
| 10/23/2013 | CN103356693A Compound low-molecular heparin sodium liposome gel and preparation method and application thereof |
| 10/23/2013 | CN103356692A Composite antibacterial gel and preparation method thereof |
| 10/23/2013 | CN103356691A Preparation method of potentilla anserina L. root crude polysaccharide with potentilla anserina L. root as raw material and use |
| 10/23/2013 | CN103356690A Injection for treating sow endometritis and preparation method thereof |
| 10/23/2013 | CN103356689A Use of Polyflavanostilbene A in preparation of drug for treating renal insufficiency |
| 10/23/2013 | CN103356688A Novel use of Polyflavanostilbene A in preparation of drugs for treating hemorrhagic fever with renal syndrome |
| 10/23/2013 | CN103356687A Use of ivermectin and its derivative |
| 10/23/2013 | CN103356686A Application of Houttuynoid B in preparation of medicine for treating or preventing chronic heart failure |
| 10/23/2013 | CN103356685A Application of Houttuynoid D in medicine for treating atherosclerosis |
| 10/23/2013 | CN103356684A Application of Houttuynoid E in vascular dilation medicine |
| 10/23/2013 | CN103356683A Application of Houttuynoid C in medicine for treating or preventing acute heart failure |
| 10/23/2013 | CN103356682A Application of Houttuynoid D in anti-platelet aggregation medicine |
| 10/23/2013 | CN103356681A Application of Houttuynoid A in preparation of medicines for treating myocardial ischemia |
| 10/23/2013 | CN103356680A Application of Houttuynoid A in preparation of anti-hypoxic medicines |
| 10/23/2013 | CN103356679A Application of Houttuynoid A in preparation of anti-platelet aggregation medicines |
| 10/23/2013 | CN103356678A Application of Houttuynoid C in anti-platelet aggregation medicines |
| 10/23/2013 | CN103356677A Application of Houttuynoid D in medicine for treating or preventing acute heart failure |
| 10/23/2013 | CN103356676A Application of Houttuynoid E in medicine for treating myocardial ischemia |
| 10/23/2013 | CN103356675A Application of Houttuynoid B in preparation of medicine for treating or preventing acute heart failure |
| 10/23/2013 | CN103356674A Application of Houttuynoid E in anti-hypoxia medicine |
| 10/23/2013 | CN103356673A Application of Houttuynoid A in preparation of medicines for treating or preventing chronic heart failure |
| 10/23/2013 | CN103356672A Application of Houttuynoid A in preparation of vasodilating medicines |
| 10/23/2013 | CN103356671A Application of Houttuynoid C in treating or preventing chronic heart failure |
| 10/23/2013 | CN103356670A Application of Houttuynoid D in medicine for treating or preventing chronic heart failure |
| 10/23/2013 | CN103356669A Application of Houttuynoid A in preparation of medicines for treating or preventing acute heart failure |
| 10/23/2013 | CN103356668A Application of Houttuynoid C in vascular dilation medicine |
| 10/23/2013 | CN103356667A Application of Houttuynoid A in preparation of medicines for treating atherosclerosis |
| 10/23/2013 | CN103356666A Application of Houttuynoid A in preparation of medicines for treating ischemic brain injury |
| 10/23/2013 | CN103356665A Application of new mangiferin to prevention and treatment of diabetic nephropathy |
| 10/23/2013 | CN103356664A Brain atrophy prevention agent |
| 10/23/2013 | CN103356663A Sulfamonomethoxine-ciprofloxacin-fosfomycin combined injection for veterinary use and preparation method thereof |
| 10/23/2013 | CN103356662A Injection tigecycline composition and preparation method thereof |
| 10/23/2013 | CN103356661A Novel capsule filled with metformin hydrochloride solid preparation and glipizide solid preparation |
| 10/23/2013 | CN103356660A Application of Chukrasone A in medicines for resisting osteoporosis caused by estrogen deficiency |
| 10/23/2013 | CN103356659A Application of Chukrasone A in preparing medicines for treating or preventing renal fibrosis |
| 10/23/2013 | CN103356658A Application of Chukrasone A in preparing medicines for treating influenza virus A |
| 10/23/2013 | CN103356657A Application of Chukrasone A in preparing vasodilating medicines |
| 10/23/2013 | CN103356656A Application of Chukrasone A in preparing medicines for treating Alzheimer disease |
| 10/23/2013 | CN103356655A Application of Chukrasone A for preparing medicines for treating chronic obstructive pulmonary disease |
| 10/23/2013 | CN103356654A Application of Chukrasone A in preparing medicines for treating hemorrhagic fever with renal syndrome |
| 10/23/2013 | CN103356653A Application of Chukrasone A in preparing medicines for treating or preventing dental ulcer |
| 10/23/2013 | CN103356652A Application of Chukrasone A in preparing MAO (Monoamine Oxidase) inhibitor medicines |
| 10/23/2013 | CN103356651A Application of Chukrasone A in preparing medicines for treating yellow fever virus infection |
| 10/23/2013 | CN103356650A Application of Chukrasone A in preparing medicines for treating respiratory syncytial virus |
| 10/23/2013 | CN103356649A Application of Chukrasone A in preparing anti-hypoxic medicines |
| 10/23/2013 | CN103356648A Application of Chukrasone A in preparing erythrocyte rising medicines |
| 10/23/2013 | CN103356647A Application of Chukrasone A in preparation medicines for treating myocardial ischemia |
| 10/23/2013 | CN103356646A Application of Chukrasone A in preparation of medicines for treating acute renal failure |
| 10/23/2013 | CN103356645A Application of Chukrasone A in preparation of medicines for preventing or treating renal insufficiency |
| 10/23/2013 | CN103356644A Application of Chukrasone A in preparation of medicines for treating ischemic brain injury |
| 10/23/2013 | CN103356643A Application of Chukrasone A to medicines for resisting aseptic inflammation |
| 10/23/2013 | CN103356642A Application of Chukrasone A in leukocyte-increasing medicines |
| 10/23/2013 | CN103356641A Compound for inhibiting p-glycoprotein |
| 10/23/2013 | CN103356640A Application of glucocorticoid in preparation of medicine used for treating and alleviating Graves ophthalmopathy |
| 10/23/2013 | CN103356639A Novel capsule filled with valsartan solid preparation and hydrochlorothiazide solid preparation |
| 10/23/2013 | CN103356638A Tablet capsule filled with irbesartan tablet and thiazole hydrochloride tablet |
| 10/23/2013 | CN103356637A Application of chaetocin in preparation of medicine used for preventing and treating heart diseases |
| 10/23/2013 | CN103356636A Theramutein调节剂 Theramutein moderator |
| 10/23/2013 | CN103356635A Application of Aspeverin in preparation of drug used for treating lung cancer |
| 10/23/2013 | CN103356634A Use of Aspeverin in preparation of drugs for treating leukemia |
| 10/23/2013 | CN103356633A Use of Aspeverin in preparation of drug for resisting helicobacter pylori (Hp) |
| 10/23/2013 | CN103356632A Use of Aspeverin in preparation of drugs for treating atherosclerosis |
| 10/23/2013 | CN103356631A Doxofylline composition for injection |
| 10/23/2013 | CN103356630A Medicinal composition containing pentoxifylline and prucalopride and medical application thereof |
| 10/23/2013 | CN103356629A Application of Myriberine A in preparing antituberculous medicines |
| 10/23/2013 | CN103356628A Use of pyrazolopyrimidine compound in pharmacy |
| 10/23/2013 | CN103356627A Use of drug in treatment on candida glabrata infected diseases |
| 10/23/2013 | CN103356626A Use of pyrazolopyrimidine compound in treatment on trichophyton rubrum-infected diseases |
| 10/23/2013 | CN103356625A Use of pyrazolopyrimidine compound in treatment on candida parapsilosis infected diseases |
| 10/23/2013 | CN103356624A Use of pyrimidine compound in antifungal drugs |
| 10/23/2013 | CN103356623A Novel ferrous fumarate and folic acid compound capsule |
| 10/23/2013 | CN103356622A Therapeutic compositions and the use thereof |
| 10/23/2013 | CN103356621A Novel capsule filled with alogliptin solid preparation and pioglitazone solid preparation |
| 10/23/2013 | CN103356620A Novel use of bisbenzylisoquinoline compounds or pharmaceutically acceptable salts thereof in treating or improving depressive symptom |
| 10/23/2013 | CN103356619A Medicinal composition |
| 10/23/2013 | CN103356618A Tropisetron composition for injection |
| 10/23/2013 | CN103356617A Application of deacetylase inhibitors in preparation of medicaments for promoting insulin secretion |
| 10/23/2013 | CN103356616A Bilastine-containing pharmaceutical composition and preparation method thereof |
| 10/23/2013 | CN103356615A Tablet capsule filled with repaglinide tablet and metformin tablet |
| 10/23/2013 | CN103356614A Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy |
| 10/23/2013 | CN103356613A Novel capsule filled with valsartan solid preparation and amlodipine solid preparation |
| 10/23/2013 | CN103356612A Pharmaceutical combination comprising an antibacterial agent and an active substance selected from thymol and carvacrol |
| 10/23/2013 | CN103356611A Application of berberine in preparation of weight-loss drug |
| 10/23/2013 | CN103356610A Application of tetrahydrocorysamine in preparation of medicine for treating senile dementia |
| 10/23/2013 | CN103356609A Compound intravenous anesthetic |
| 10/23/2013 | CN103356608A Application of Fluevirosines A in preparing anti-helicobacter pylori medicines |
| 10/23/2013 | CN103356607A Application of cajanolactone A in preparation of medicine used for treating osteoporosis |
| 10/23/2013 | CN103356606A Novel use of aesculetin |
| 10/23/2013 | CN103356605A Application of Chukrasone B in preparing medicines for treating acute renal failure |
| 10/23/2013 | CN103356604A Application of Chukrasone B in preparing medicines for treating atherosclerosis |
| 10/23/2013 | CN103356603A Application of Chukrasone B in preparing medicines for treating yellow fever virus infection |
| 10/23/2013 | CN103356602A Application of Chukrasone B in medicines for resisting osteoporosis caused by estrogen deficiency |
| 10/23/2013 | CN103356601A Application of Chukrasone B in preparing MAO (Monoamine Oxidase) inhibitor medicines |
| 10/23/2013 | CN103356600A Application of Chukrasone B in anti-helicobacter pylori medicines |
| 10/23/2013 | CN103356599A Application of Chukrasone B in antidepressant medicines |
| 10/23/2013 | CN103356598A Application of Chukrasone B in preparing anti-platelet aggregation medicines |
| 10/23/2013 | CN103356597A Application of Chukrasone B in preparing medicines for treating dengue virus infection |
| 10/23/2013 | CN103356596A Application of Chukrasone B in preparation medicines for treating influenza virus A |
| 10/23/2013 | CN103356595A Application of Chukrasone B in preparation medicines for treating myocardial ischemia |